XML 29 R5.htm IDEA: XBRL DOCUMENT v3.23.1
CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY - USD ($)
Ordinary shares
Preferred shares
Additional paid-in capital
Accumulated earnings (deficit)
Statutory reserves
Accumulated Other Comprehensive income (loss)
Total shareholders' equity
Non-controlling interest
Total
Balance at beginning at Dec. 31, 2019 $ 4,000 $ 0 $ 5,499,000 $ (1,557,000) $ 8,000 $ 61,000 $ 4,015,000 $ 0 $ 4,015,000
Balance at beginning (in shares) at Dec. 31, 2019 74,035,502 0              
STATEMENTS OF CHANGES IN EQUITY                  
Shareholder investment     8,096,000       8,096,000   8,096,000
Capital divestments     (5,963,000)       (5,963,000)   (5,963,000)
Net loss       (166,000)     (166,000)   (166,000)
Foreign currency translation adjustment           181,000 181,000   181,000
Foreign currency translation adjustment, net of nil income taxes           181,000 181,000   181,000
Balance at ending at Dec. 31, 2020 $ 4,000   7,632,000 (1,723,000) 8,000 242,000 6,163,000   6,163,000
Balance at ending (in shares) at Dec. 31, 2020 74,035,502                
STATEMENTS OF CHANGES IN EQUITY                  
Net loss       (196,579,000)     (196,579,000) 651,000 (195,928,000)
Foreign currency translation adjustment           395,000 395,000 117,000 512,000
Reverse acquisition $ 3,000 $ 1,000 167,756,000       167,760,000 7,649,000 175,409,000
Reverse acquisition (in shares) 69,424,993 6,000              
Vesting of restricted shares award $ 1,000   40,335,000       40,336,000   40,336,000
Vesting of restricted shares award (in shares) 18,580,015                
Share-based compensation-option     1,254,000       1,254,000   1,254,000
Series A preferred shares conversion $ 0 $ 0 1,436,000 0 0 0 1,436,000 0 1,436,000
Series A preferred shares conversion (shares) 1,089,145                
Contingent liabilities assumed by Renren Inc.     8,897,000       8,897,000   8,897,000
Foreign currency translation adjustment, net of nil income taxes           395,000 395,000 117,000 512,000
Balance at ending at Dec. 31, 2021 $ 8,000 $ 1,000 227,310,000 (198,302,000) 8,000 637,000 29,662,000 8,417,000 38,079,000
Balance at ending (in shares) at Dec. 31, 2021 163,129,655 6,000              
STATEMENTS OF CHANGES IN EQUITY                  
Shareholder investment               665,000 665,000
Net loss       (84,706,000)     (84,706,000) 87,000 (84,619,000)
Issuance of ordinary shares and warrant for private placement $ 1,000   4,243,000       4,244,000   4,244,000
Issuance of ordinary shares and warrant for private placement (in shares) 4,406,542                
Dispose subsidiaries           (2,060,000) (2,060,000) (3,954,000) (6,014,000)
Issuance of preferred shares   $ 2,000 24,591,000       24,593,000   24,593,000
Issuance of preferred shares (in shares)   50,000              
Foreign currency translation adjustment           2,893,000 2,893,000 (1,027,000) 1,866,000
Vesting of restricted shares award $ 1,000   39,309,000       39,310,000   39,310,000
Vesting of restricted shares award (in shares) 38,911,291                
Issuance of ordinary shares held in escrow $ 1,000   17,378,000       17,379,000   17,379,000
Issuance of ordinary shares held in escrow (in shares) 21,802,722                
Foreign currency translation adjustment, net of nil income taxes           2,893,000 2,893,000 (1,027,000) 1,866,000
Balance at ending at Dec. 31, 2022 $ 11,000 $ 3,000 $ 312,831,000 $ (283,008,000) $ 8,000 $ 1,470,000 $ 31,315,000 $ 4,188,000 $ 35,503,000
Balance at ending (in shares) at Dec. 31, 2022 228,250,210 56,000